[Neurologic diseases associated with the HTLV-1 virus in Panama]. 1990

F Gracia, and L Castillo, and S L de Lao, and C A Archibold, and M Larreátegui, and W C Reeves, and P Levine
División de Epidemiología, Laboratorio Conmemorativo Gorgas, Panamá.

Studies of the prevalence of the human T-cell lymphotropic virus (HTLV-1) in 1984 to 1986 in the Republic of Panama revealed a national seroprevalence of 1 to 2%. Since 1985 clinical epidemiological studies of neurological diseases associated to HTLV-1 are being done. Two hundred and fitly six clinical cases of thirty eight different neurological diseases of unknown etiology studied in the Neurology Services of the Santo Tomas Hospital and the Social Security Metropolitan Hospital Complex have been associated in some way to the HTLV-1. Twelve cases of progressive spastic paraparesis were identified and related to HLTV-1 as an etiologic agent. The ratio of men to women was maintained at 1:1 with the average age at onset at 44 years and without racial preference. There are important doubts about the association of this virus to multiple sclerosis. The seroprevalence of the HTLV-1 virus in Panama is found to be similar to that reported in neighboring countries and the association of tropical spastic paraparesis to THLV-1 infection is identified.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D010176 Panama A country in CENTRAL AMERICA, bordering both the Caribbean Sea and the North Pacific Ocean, between COLOMBIA and COSTA RICA.
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015481 HTLV-I Antibodies Antibodies reactive with the HTLV-I ANTIGENS. ATLV Antibodies,Human T-Cell Leukemia Virus I Antibodies,Leukemia-Lymphoma Virus I Antibodies, Human T-Cell,T-Cell Leukemia Virus I Antibodies, Adult,T-Cell Leukemia Virus I Antibodies, Human,HTLV I Antibodies,Human T Cell Leukemia Virus I Antibodies,Leukemia Lymphoma Virus I Antibodies, Human T Cell,T Cell Leukemia Virus I Antibodies, Adult,T Cell Leukemia Virus I Antibodies, Human,Antibodies, ATLV,Antibodies, HTLV I,Antibodies, HTLV-I,I Antibodies, HTLV
D016036 Seroepidemiologic Studies EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases. Seroprevalence,Seroepidemiologic Study,Seroepidemiological Study,Studies, Seroepidemiologic,Study, Seroepidemiologic,Seroepidemiological Studies,Seroprevalences,Studies, Seroepidemiological,Study, Seroepidemiological

Related Publications

F Gracia, and L Castillo, and S L de Lao, and C A Archibold, and M Larreátegui, and W C Reeves, and P Levine
June 1989, Lakartidningen,
F Gracia, and L Castillo, and S L de Lao, and C A Archibold, and M Larreátegui, and W C Reeves, and P Levine
October 1997, International journal of hematology,
F Gracia, and L Castillo, and S L de Lao, and C A Archibold, and M Larreátegui, and W C Reeves, and P Levine
January 1989, Revue neurologique,
F Gracia, and L Castillo, and S L de Lao, and C A Archibold, and M Larreátegui, and W C Reeves, and P Levine
September 2008, Blood,
F Gracia, and L Castillo, and S L de Lao, and C A Archibold, and M Larreátegui, and W C Reeves, and P Levine
December 2000, La Revue de medecine interne,
F Gracia, and L Castillo, and S L de Lao, and C A Archibold, and M Larreátegui, and W C Reeves, and P Levine
April 2023, JCI insight,
F Gracia, and L Castillo, and S L de Lao, and C A Archibold, and M Larreátegui, and W C Reeves, and P Levine
January 2010, Journal of clinical and experimental hematopathology : JCEH,
F Gracia, and L Castillo, and S L de Lao, and C A Archibold, and M Larreátegui, and W C Reeves, and P Levine
March 2020, Seminars in diagnostic pathology,
F Gracia, and L Castillo, and S L de Lao, and C A Archibold, and M Larreátegui, and W C Reeves, and P Levine
March 2018, The British journal of ophthalmology,
F Gracia, and L Castillo, and S L de Lao, and C A Archibold, and M Larreátegui, and W C Reeves, and P Levine
July 1992, Releve epidemiologique hebdomadaire,
Copied contents to your clipboard!